• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性门静脉高压症和肝外门静脉阻塞。

Idiopathic portal hypertension and extrahepatic portal venous obstruction.

机构信息

Department of Pediatric Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.

Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, 110070, India.

出版信息

Hepatol Int. 2018 Feb;12(Suppl 1):148-167. doi: 10.1007/s12072-018-9844-3. Epub 2018 Feb 20.

DOI:10.1007/s12072-018-9844-3
PMID:29464506
Abstract

BACKGROUND

Idiopathic portal hypertension (IPH) and extrahepatic portal venous obstruction (EHPVO) are non-cirrhotic vascular causes of portal hypertension (PHT). Variceal bleed and splenomegaly are the commonest presentations.

AIM

The present review is intended to provide the existing literature on etiopathogenesis, clinical profile, diagnosis, natural history and management of IPH and EHPVO.

RESULTS

IPH and EHPVO are both characterized by normal hepatic venous pressure gradient, moderate to massive splenomegaly with preserved liver synthetic functions. While the level of block in IPH is presinusoidal, in EHPVO it is at prehepatic level. Infections, autoimmunity, drugs, immunodeficiency and prothrombotic states are possible etiological agents in IPH. Contrastingly in EHPVO, prothrombotic disorders and local factors around the portal vein are the incriminating factors. Diagnosis is often clinical, supported by simple radiological tools. Natural history is defined by episodes of variceal bleed and symptoms related to enlarged spleen. Growth failure, portal biliopathy and minimal hepatic encephalopathy are additional concerns in EHPVO. Long-term survival is reasonably good with endoscopic surveillance; however, parenchymal extinction leading to decompensation is seen in a minority of patients in both the disorders. Surgical shunts revert the complications secondary to PHT. Meso-Rex shunt has become the standard surgery in children with EHPVO.

CONCLUSION

This review gives a detailed summary of these two vascular conditions of liver-IPH and EHPVO. Further research is needed to understand the pathogenesis and natural history of these disorders.

摘要

背景

特发性门静脉高压症(IPH)和肝外门静脉阻塞(EHPVO)是非肝硬化性门静脉高压症(PHT)的非肝血管原因。静脉曲张出血和脾肿大是最常见的表现。

目的

本综述旨在提供关于 IPH 和 EHPVO 的病因发病机制、临床特征、诊断、自然史和治疗的现有文献。

结果

IPH 和 EHPVO 的特点均为正常肝静脉压力梯度、中等至大量脾肿大伴保留肝脏合成功能。虽然 IPH 的阻塞程度为窦前性,而 EHPVO 的阻塞程度为肝前性。在 IPH 中,感染、自身免疫、药物、免疫缺陷和血栓形成状态可能是病因。相反,在 EHPVO 中,血栓形成紊乱和门静脉周围的局部因素是罪魁祸首。诊断通常是临床的,辅以简单的影像学工具。自然史由静脉曲张出血和肿大脾脏相关症状定义。生长发育迟缓、门静脉胆病和轻微肝性脑病是 EHPVO 的其他关注点。内镜监测的长期生存情况良好,但在这两种疾病中,少数患者会出现实质消失导致失代偿。手术分流术可逆转 PHT 引起的并发症。在 EHPVO 患儿中,Meso-Rex 分流术已成为标准手术。

结论

本综述详细总结了这两种肝脏血管疾病-IPH 和 EHPVO。需要进一步研究来了解这些疾病的发病机制和自然史。

相似文献

1
Idiopathic portal hypertension and extrahepatic portal venous obstruction.特发性门静脉高压症和肝外门静脉阻塞。
Hepatol Int. 2018 Feb;12(Suppl 1):148-167. doi: 10.1007/s12072-018-9844-3. Epub 2018 Feb 20.
2
Noncirrhotic Portal Hypertension: Current and Emerging Perspectives.非肝硬化性门静脉高压:当前和新兴的观点。
Clin Liver Dis. 2019 Nov;23(4):781-807. doi: 10.1016/j.cld.2019.07.006.
3
Non-cirrhotic portal hypertension - diagnosis and management.非肝硬化性门静脉高压症——诊断与管理。
J Hepatol. 2014 Feb;60(2):421-41. doi: 10.1016/j.jhep.2013.08.013. Epub 2013 Aug 23.
4
Non-cirrhotic portal hypertension.非肝硬化性门静脉高压症
Clin Liver Dis. 2014 May;18(2):451-76. doi: 10.1016/j.cld.2014.01.009.
5
Advantages of the meso-Rex bypass compared with portosystemic shunts in the management of extrahepatic portal vein obstruction in children.与门体静脉分流术相比,Meso-Rex 旁路在儿童肝外门静脉阻塞管理中的优势。
J Am Coll Surg. 2013 Jan;216(1):83-9. doi: 10.1016/j.jamcollsurg.2012.09.013. Epub 2012 Nov 21.
6
Etiological spectrum of esophageal varices due to portal hypertension in Indian children: is it different from the West?印度儿童门静脉高压所致食管静脉曲张的病因谱:与西方有差异吗?
J Gastroenterol Hepatol. 2008 Sep;23(9):1354-7. doi: 10.1111/j.1440-1746.2007.05102.x. Epub 2007 Aug 6.
7
Clinical features of idiopathic portal hypertension in China: A retrospective study of 338 patients and literature review.中国特发性门静脉高压症的临床特征:一项回顾性研究 338 例患者和文献复习。
J Gastroenterol Hepatol. 2019 Aug;34(8):1417-1423. doi: 10.1111/jgh.14552. Epub 2018 Dec 16.
8
Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature.非肝硬化性门脉纤维化(特发性门脉高压症):151例患者的经验及文献综述
J Gastroenterol Hepatol. 2002 Jan;17(1):6-16. doi: 10.1046/j.1440-1746.2002.02596.x.
9
Role of endothelial-mesenchymal transition in idiopathic portal hypertension.特发性门静脉高压症中内皮-间充质转化的作用。
Histol Histopathol. 2013 Feb;28(2):145-54. doi: 10.14670/HH-28.145.
10
Idiopathic portal hypertension: natural history and long-term outcome.特发性门静脉高压症:自然病史和长期预后。
Hepatology. 2014 Jun;59(6):2276-85. doi: 10.1002/hep.26904. Epub 2014 Feb 28.

引用本文的文献

1
Case Report: Partial Splenic Artery Embolization for the Treatment of Painful Splenomegaly Secondary to Noncirrhotic Portal Hypertension.病例报告:部分脾动脉栓塞术治疗非肝硬化门静脉高压继发的疼痛性脾肿大
Case Reports Hepatol. 2025 Jun 6;2025:9303407. doi: 10.1155/crhe/9303407. eCollection 2025.
2
Gut microbiota analysis in cirrhosis and non-cirrhotic portal hypertension suggests that portal hypertension can be main factor of cirrhosis-specific dysbiosis.肝硬化和非肝硬化门静脉高压症的肠道微生物群分析表明,门静脉高压可能是肝硬化特异性生态失调的主要因素。
Sci Rep. 2025 Mar 11;15(1):8394. doi: 10.1038/s41598-025-92618-0.
3

本文引用的文献

1
Noncirrhotic Portal Fibrosis in Pediatric Population.儿童非肝硬化性门脉纤维化
J Pediatr Gastroenterol Nutr. 2017 May;64(5):748-753. doi: 10.1097/MPG.0000000000001485.
2
Outcomes of partial splenic embolization in patients with massive splenomegaly due to idiopathic portal hypertension.特发性门静脉高压所致巨脾患者行部分脾栓塞术的疗效
World J Gastroenterol. 2016 Nov 21;22(43):9623-9630. doi: 10.3748/wjg.v22.i43.9623.
3
Antithrombotic treatment with direct-acting oral anticoagulants in patients with splanchnic vein thrombosis and cirrhosis.
Idiopathic non-cirrhotic portal hypertension: A case report.
特发性非肝硬化性门静脉高压症:一例报告。
Medicine (Baltimore). 2024 Dec 20;103(51):e40642. doi: 10.1097/MD.0000000000040642.
4
The effectiveness of endoscopic sclerotherapy in the treatment of esophageal varices in children with prehepatic portal hypertension.内镜下硬化疗法治疗肝前性门静脉高压症患儿食管静脉曲张的疗效
Pediatr Surg Int. 2024 Dec 20;41(1):36. doi: 10.1007/s00383-024-05938-z.
5
Application of liver biopsy in etiological diagnosis of unexplained portal hypertension: Porto-sinusoidal vascular disease should not be ignored.肝活检在不明原因门静脉高压病因诊断中的应用:门体静脉血管病变不容忽视。
Medicine (Baltimore). 2024 Sep 27;103(39):e39819. doi: 10.1097/MD.0000000000039819.
6
Management of extensive portal vein thrombosis via thrombolysis and thrombectomy without underlying liver disease: A case report.无潜在肝脏疾病情况下通过溶栓和血栓切除术治疗广泛门静脉血栓形成:一例报告
Clin Case Rep. 2024 Jul 1;12(7):e8920. doi: 10.1002/ccr3.8920. eCollection 2024 Jul.
7
Noncirrhotic portal hypertension-Historical perspectives bring clarity to the entity and its management.非肝硬化性门静脉高压症——历史视角为该疾病及其管理带来了清晰认识。
Clin Liver Dis (Hoboken). 2024 Jun 14;23(1):e0232. doi: 10.1097/CLD.0000000000000232. eCollection 2024 Jan-Jun.
8
Clinical features of extrahepatic portal vein obstruction: Myeloproliferative neoplasms eliminate hypersplenic hematologic changes in extrahepatic portal vein obstruction.肝外门静脉阻塞的临床特征:骨髓增殖性肿瘤消除肝外门静脉阻塞中的脾功能亢进血液学改变。
Intractable Rare Dis Res. 2024 Feb;13(1):63-68. doi: 10.5582/irdr.2023.01106.
9
Non-cirrhotic intrahepatic portal hypertension: Is the gun loaded?非肝硬化性肝内门静脉高压症:枪上膛了吗?
Indian J Gastroenterol. 2024 Apr;43(2):285-287. doi: 10.1007/s12664-023-01466-1.
10
Endovascular treatment of symptomatic hepatic venous outflow obstruction post major liver resection.大肝切除术后症状性肝静脉流出道梗阻的血管内治疗。
BMC Gastroenterol. 2023 Jul 17;23(1):241. doi: 10.1186/s12876-023-02876-3.
内脏静脉血栓形成和肝硬化患者使用直接口服抗凝剂的抗栓治疗
Liver Int. 2017 May;37(5):694-699. doi: 10.1111/liv.13285. Epub 2016 Nov 19.
4
Spectrum of biliary abnormalities in portal cavernoma cholangiopathy (PCC) secondary to idiopathic extrahepatic portal vein obstruction (EHPVO)-a prospective magnetic resonance cholangiopancreaticography (MRCP) based study.特发性肝外门静脉阻塞(EHPVO)继发门静脉海绵样变性胆管病(PCC)的胆道异常谱——一项基于磁共振胰胆管造影(MRCP)的前瞻性研究
Br J Radiol. 2016 Dec;89(1068):20160636. doi: 10.1259/bjr.20160636. Epub 2016 Oct 12.
5
Portal hypertension in children: High-risk varices, primary prophylaxis and consequences of bleeding.儿童门静脉高压症:高危静脉曲张、一级预防和出血后果。
J Hepatol. 2017 Feb;66(2):320-327. doi: 10.1016/j.jhep.2016.09.006. Epub 2016 Sep 20.
6
Novel Rat Model of Repetitive Portal Venous Embolization Mimicking Human Non-Cirrhotic Idiopathic Portal Hypertension.模拟人类非肝硬化性特发性门静脉高压的新型大鼠反复门静脉栓塞模型
PLoS One. 2016 Sep 2;11(9):e0162144. doi: 10.1371/journal.pone.0162144. eCollection 2016.
7
Toward a Comprehensive New Classification of Portal Vein Thrombosis in Patients With Cirrhosis.肝硬化患者门静脉血栓形成的全面新分类研究
Gastroenterology. 2016 Oct;151(4):574-577.e3. doi: 10.1053/j.gastro.2016.08.033. Epub 2016 Aug 27.
8
Imaging and radiological interventions in extra-hepatic portal vein obstruction.肝外门静脉阻塞的影像学及放射介入治疗
World J Radiol. 2016 Jun 28;8(6):556-70. doi: 10.4329/wjr.v8.i6.556.
9
Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension.经颈静脉肝内门体分流术在特发性非肝硬化性门静脉高压症严重并发症管理中的作用。
Hepatology. 2016 Jul;64(1):224-31. doi: 10.1002/hep.28547. Epub 2016 May 13.
10
High patency of proximal splenorenal shunt: A myth or reality ? - A prospective cohort study.近端脾肾分流术的高通畅率:神话还是现实?——一项前瞻性队列研究。
Int J Surg. 2016 Mar;27:82-87. doi: 10.1016/j.ijsu.2015.12.071. Epub 2016 Jan 20.